Jpmorgan Chase & CO Armata Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 27 shares of ARMP stock, worth $63. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 26
3.85%
Holding current value
$63
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.4MCall Options Held
100Put Options Held
56.7K-
Bank Of America Corp Charlotte, NC634KShares$1.49 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA206KShares$483,5190.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$250,2490.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$235,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX90.4KShares$212,3970.01% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $84.9M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...